Marcia Frellick's profile photo

Marcia Frellick

Chicago

Healthcare Writer at Freelance

-TCG WORLD-Trader/crypto|BAPC | Thieves List | MEEPS | The Matic Greys | FMFH | Cyber Hornets/Animus | Elongator | 🐲DRC 2 |

Featured in: Favicon webmd.com Favicon phys.org Favicon medscape.com (+2) Favicon sciencenews.org Favicon medicalxpress.com Favicon medicinenet.com Favicon khn.org Favicon geneticliteracyproject.org Favicon mdedge.com Favicon goodrx.com

Articles

  • Spike in Asthma ED Visits After Wildfires a ‘Wake-Up Call’

    1 week ago | medscape.com | Marcia Frellick

    In 2023, Canada’s most destructive wildfire season on record, asthma-related emergency department (ED) visits in Ontario substantially increased, but the numbers differed greatly by age and timing of the exposure, data indicated.

  • Commission Calls for Urgent Action on Women’s Cancer Inequities

    1 week ago | oncologynewscentral.com | Marcia Frellick

    The Lancet Commission on women, power, and cancer has outlined ways to practically implement 10 key recommendations aimed at addressing inequities and measuring progress in cancer care and outcomes for women.

  • Confirmatory Test for Primary Aldosteronism May Slow Care

    1 week ago | medscape.com | Marcia Frellick

    For patients who already have a positive result on a screening test for primary aldosteronism (PA), confirmatory testing with the seated saline suppression test (SSST) adds little to the diagnostic work-up and may delay proper and timely care, according to a study published in the Annals of Internal Medicine. The SSST may misinform treatment decisions and lead to missed chances for intervention “even in patients who would clearly respond to treatment,” the authors wrote, led by Alexander A.

  • New Safety Questions Over Mechanical Circulatory Support

    1 week ago | medscape.com | Marcia Frellick

    For circulatory support in cardiogenic shock, the best choice between Impella and intra-aortic balloon pump (IABP) has been controversial. Now, new data is complicating the debate. Presenting at the Society for Cardiovascular Angiography and Interventions in Washington, DC, Godbless Ajenaghughrure, MD, an internist and resident at Trihealth Good Samaritan Hospital in Cincinnati, Ohio, reported that Impella use is associated with higher 30-day mortality compared to IABP.

  • FDA Approves First One-Time Treatment for RDEB Wounds

    2 weeks ago | medscape.com | Marcia Frellick

    Today, the US Food and Drug Administration (FDA) approved prademagene zamikeracel cellular sheets (pz-cel, Zevaskyn), the first autologous cell-based gene therapy for treating wounds in adults and children with recessive dystrophic epidermolysis bullosa (RDEB), a rare, debilitating genetic skin disease. RDEB has no cure, and patients often have large open wounds with a high risk of systemic infection.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
508
Tweets
188
DMs Open
No
AlenaFa
AlenaFa @mfrellick
19 Mar 23

I only got 1728 ARB in the airdrop you? @dacookingsenpai @shingimc @MikeTaormina @Prodiproy936 @SvorobNikita @queenola16 @SansMarko @yasin_demir59 @tvanleiden @Bonewinn @almazrouii @_NathanMuir_ @AshikAs87590051 @BenNFT_Lover

Twitter User @user

AlenaFa
AlenaFa @mfrellick
7 Oct 22

RT @mattmoog: It’s a historic day for the Chicago Sun-Times! We’ve just taken down the paywall on @SunTimes. Now you can read all of our ne…

AlenaFa
AlenaFa @mfrellick
3 May 21

https://t.co/kXMU8t2j5J